As we inch warily or rush enthusiastically into another year against a backdrop of political turmoil and business uncertainty in major markets, it is time to look at the prevailing 2019 pharmaceutical industry trends and what they might mean for companies launching new medicines, negotiating market access barriers, or simply trying to do what they do better. Inevitably, the US is in the thick of the action. But there are many other important 2019 pharma trends, both national and global, that will set the pace for industry throughout what promises to be another dynamic and challenging year.
What does 2018 have in store for the pharmaceutical and biotech industry? In our new '6 Pharma Trends for 2018 Infographic' we look at the key trends that we believe will shape the operating environment for the industry over the year ahead.
The pharmaceutical market is always challenging, and 2017 has been no exception. As we look ahead to some key pharma trends for 2018, we find certain hardy perennials, such as drug pricing, that re-emerge in new iterations year after year.
As the challenges to pharmaceutical launch strategy, market access and success, become ever more imposing, no-one will prevail by throwing money and reps at the problem as companies did in the past.
A healthy pharmaceutical industry runs on innovation. There is plenty of that left in the tank, judging by current market trends and product development pipelines. Pharma launch challenges, though, have never been tougher.